These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 32532690

  • 1. Preoperative plasmapheresis experience in Graves' disease patients with anti-thyroid drug-induced hepatotoxicity.
    Apaydın T, Elbasan O, Yavuz DG.
    Transfus Apher Sci; 2020 Oct; 59(5):102826. PubMed ID: 32532690
    [Abstract] [Full Text] [Related]

  • 2. Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs.
    Apaydin T, Gogas Yavuz D.
    Ther Apher Dial; 2021 Dec; 25(6):877-883. PubMed ID: 33661574
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis.
    Min SH, Phung A, Oh TJ, Han KS, Kim MJ, Kim JM, Lee JH, Park YJ.
    J Korean Med Sci; 2015 Oct; 30(10):1531-4. PubMed ID: 26425054
    [Abstract] [Full Text] [Related]

  • 4. [Plasmapheresis before thyroidectomy in a patient with thyrotoxicosis and hepatotoxicity by propylthiouracil: case report].
    Almeida RF, Comarella AP, Silveira MB, Silva AR, Ferri Casini A.
    Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):322-6. PubMed ID: 23828438
    [Abstract] [Full Text] [Related]

  • 5. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A.
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasmapheresis in thyrotoxicosis: a single-center case series.
    Rami I, Zerrouki D, Assarrar I, Rouf S, Latrech H.
    J Med Case Rep; 2024 Mar 30; 18(1):193. PubMed ID: 38553729
    [Abstract] [Full Text] [Related]

  • 8. An unusual evolution of thyroid function after therapeutic plasma exchange in Graves' disease with cholestatic jaundice: A case report.
    Jin Y, Feng X, Ni H.
    Medicine (Baltimore); 2024 Feb 23; 103(8):e37074. PubMed ID: 38394504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of 24-Hour Electrocardiogram Parameters in Patients with Graves' Disease Before and After Anti-Thyroid Therapy.
    Akkuş G, Sökmen Y, Yılmaz M, Bekler Ö, Akkuş O.
    Endocr Metab Immune Disord Drug Targets; 2021 Feb 23; 21(1):183-191. PubMed ID: 32727336
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M, Castagnone D, Rivolta R, Meroni L, Pappalettera M, Cantalamessa L.
    Thyroid; 1997 Dec 23; 7(6):823-8. PubMed ID: 9459623
    [Abstract] [Full Text] [Related]

  • 14. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun 23; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y, Takeoka K, Amino N.
    Endocr J; 2005 Aug 23; 52(4):493-7. PubMed ID: 16127219
    [Abstract] [Full Text] [Related]

  • 16. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.
    Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S.
    J Clin Apher; 2009 Aug 23; 24(3):111-4. PubMed ID: 19484727
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct 23; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema.
    Bilir BE, Atile NS, Kirkizlar O, Kömürcü Y, Akpinar S, Sezer A, Demir M, Hekimoğlu S.
    Gynecol Endocrinol; 2013 May 23; 29(5):508-10. PubMed ID: 23383744
    [Abstract] [Full Text] [Related]

  • 19. Role of plasma exchange in autoimmune hyperthyroidism complicated by severe tiamazol-induced cholestatic jaundice.
    Miljić D, Stojanović M, Ješić R, Bogadnović G, Popović V.
    Transfus Apher Sci; 2013 Oct 23; 49(2):354-6. PubMed ID: 23756266
    [Abstract] [Full Text] [Related]

  • 20. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
    Nonchev BI, Terzieva DD, Dimov RS, Mateva NG, Tsvetkova TZ, Dimitrakov DY.
    Folia Med (Plovdiv); 2005 Oct 23; 47(3-4):40-5. PubMed ID: 16761393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.